Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...
13h
Hosted on MSNOzempic Now FDA-Approved for Kidney Disease-Here's What to KnowGLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
Patients with chronic kidney disease and those who have had a kidney transplant should avoid high doses of vitamin D, according to an evidence-based consensus document. “Vitamin D deficiency is common ...
A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...
Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.
Proton has started construction of a new electric vehicle (EV) production plant at its Tanjong Malim base, marked today by a ceremony officiated by Perak Menteri Besar Datuk Seri Saarani Mohamad. The ...
Chronic kidney disease is a common complication for people living with type 2 diabetes. Diabetes is the leading cause of ...
Patients with CKD who use antiresorptive drugs for tumor-related disorders or oral corticosteroids may be at increased risk for osteonecrosis of the jaw.
Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...
ProKidney’s Rilparencel shows promise for CKD patients, with Phase 2 data expected in 2025. Learn why PROK stock is a “Buy” ...
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results